Impact of Regional Healthcare Policy Interventions on Biosimilar Use: A 10-year Evaluation of TNFα Inhibitors Utilization in Italy
- DOI
- 10.1007/s40290-026-00629-7
- Published
- 2026-08-18
- Container
- Pharmaceutical Medicine
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s40290-026-00629-7,
title = {Impact of Regional Healthcare Policy Interventions on Biosimilar Use: A 10-year Evaluation of TNFα Inhibitors Utilization in Italy},
author = {Giacomo Vitturi and Luca Piccoli and Andrea Spini and Giorgia Pellegrini and Luca L’Abbate and Chiara Bellitto and Ylenia Ingrasciotta and Olivia Leoni and Arianna Mazzone and Domenica Ancona and Paolo Stella and Anna Cavazzana and Angela Scapin and Sara Lopes and Valeria Belleudi and Stefano Ledda and Paolo Carta and Paola Rossi and Lucian Ejlli and Ester Sapigni and Aurora Puccini and Rita Francesca Scarpelli and Giovambattista De Sarro and Alessandra Allotta and Sebastiano Addario Pollina and Roberto Da Cas and Giampaolo Bucaneve and Antea Maria Pia Mangano and Francesco Balducci and Carla Sorrentino and Ilenia Senesi and Marco Tuccori and Rosa Gini and Ugo Trama and Francesca Futura Bernardi and Flavia Mayer and Stefania Spila Alegiani and Marco Massari and Silvia Adami and Giovanna Scroccaro and Gianluca Trifirò},
year = {2026},
journal = {Pharmaceutical Medicine},
doi = {10.1007/s40290-026-00629-7},
url = {https://doi.org/10.1007/s40290-026-00629-7}
}RIS
TY - JOUR TI - Impact of Regional Healthcare Policy Interventions on Biosimilar Use: A 10-year Evaluation of TNFα Inhibitors Utilization in Italy AU - Giacomo Vitturi AU - Luca Piccoli AU - Andrea Spini AU - Giorgia Pellegrini AU - Luca L’Abbate AU - Chiara Bellitto AU - Ylenia Ingrasciotta AU - Olivia Leoni AU - Arianna Mazzone AU - Domenica Ancona AU - Paolo Stella AU - Anna Cavazzana AU - Angela Scapin AU - Sara Lopes AU - Valeria Belleudi AU - Stefano Ledda AU - Paolo Carta AU - Paola Rossi AU - Lucian Ejlli AU - Ester Sapigni AU - Aurora Puccini AU - Rita Francesca Scarpelli AU - Giovambattista De Sarro AU - Alessandra Allotta AU - Sebastiano Addario Pollina AU - Roberto Da Cas AU - Giampaolo Bucaneve AU - Antea Maria Pia Mangano AU - Francesco Balducci AU - Carla Sorrentino AU - Ilenia Senesi AU - Marco Tuccori AU - Rosa Gini AU - Ugo Trama AU - Francesca Futura Bernardi AU - Flavia Mayer AU - Stefania Spila Alegiani AU - Marco Massari AU - Silvia Adami AU - Giovanna Scroccaro AU - Gianluca Trifirò PY - 2026 JO - Pharmaceutical Medicine DO - 10.1007/s40290-026-00629-7 UR - https://doi.org/10.1007/s40290-026-00629-7 ER -
APA
Vitturi, G., Piccoli, L., Spini, A., Pellegrini, G., L’Abbate, L., Bellitto, C., Ingrasciotta, Y., Leoni, O., Mazzone, A., Ancona, D., Stella, P., Cavazzana, A., Scapin, A., Lopes, S., Belleudi, V., Ledda, S., Carta, P., Rossi, P., Ejlli, L., Sapigni, E., Puccini, A., Scarpelli, R. F., Sarro, G. D., Allotta, A., Pollina, S. A., Cas, R. D., Bucaneve, G., Mangano, A. M. P., Balducci, F., Sorrentino, C., Senesi, I., Tuccori, M., Gini, R., Trama, U., Bernardi, F. F., Mayer, F., Alegiani, S. S., Massari, M., Adami, S., Scroccaro, G., & Trifirò, G. (2026). Impact of Regional Healthcare Policy Interventions on Biosimilar Use: A 10-year Evaluation of TNFα Inhibitors Utilization in Italy. Pharmaceutical Medicine. https://doi.org/10.1007/s40290-026-00629-7
Source records
- crossref · retrieved 2026-11-08T18:37:53.331Z